Omega Design Corporation Introduces LabelSync 450 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Omega Design Corporation Introduces LabelSync 450

Pharmaceutical Technology
Volume 37, Issue 9, pp. 14
Omega LabelSync 450

Omega Design Corporation offers the LabelSync 450 Vision Module, designed to capture and sync a bottle’s unique serialized label with its individual line code. The machine can handle bottles 30-1500 mL in volume at speeds up to 300 per minute. Compatible with a range of serialization software and vision components, the LabelSync 450 verifies each code’s readability, confirms that each bottle belongs on the line, establishes a one-to-one relationship between the two codes, and enables high-integrity identification processes downstream. The LabelSync 450’s vision system is comprised of four cameras whose combined viewpoints offer 360-degree label inspection, as well as a fifth camera to read secondary line code.

Omega Design Corporation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here